title: Is intensive insulin therapy safe in the critically ill?
authors.forename: Mohamed Y
authors.initials: MY
authors.lastname: Rady
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000633:toxicity; D016465:Bone Marrow Purging / Q000009:adverse effects; D016026:Bone Marrow Transplantation; D003422:Critical Care; D016207:Cytokines / Q000097:blood; D005950:Glucose Solution, Hypertonic / Q000008:administration & dosage*; D006333:Heart Failure / Q000139:chemically induced / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006440:Hemofiltration; D006801:Humans; D007262:Infusions, Intravenous; D007328:Insulin / Q000008:administration & dosage*; D008223:Lymphoma / Q000188:drug therapy; D011188:Potassium / Q000008:administration & dosage*; D012772:Shock, Septic / Q000188:drug therapy*
chemical_list: D016207:Cytokines; D005950:Glucose Solution, Hypertonic; D007328:Insulin; D011188:Potassium